Search research articles
Contact Us
Filters
Showing results (21-30 of 95) with videos related to
Page
of 10
Sort By:
Pharmaceutical Patent Analyst
|
June 11, 2021
Cannabinoid receptor type 2 ligands: an analysis of granted patents since 2010
Benjamin Brennecke, Thais Gazzi, Kenneth Atz, et al.
Biochemical Pharmacology
|
March 9, 2026
Exploring the binding kinetics of intracellular allosteric antagonists for CC chemokine receptor 2 - a key to improve insurmountable antagonism
Yao Yao, Lisa S den Hollander, Bente Bleijs, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 2, 2006
Structure-based design of indole propionic acids as novel PPARalpha/gamma co-agonists
Bernd Kuhn, Hans Hilpert, Jörg Benz, et al.
Chemmedchem
|
April 11, 2012
Comparative molecular profiling of the PPARα/γ activator aleglitazar: PPAR selectivity, activity and interaction with cofactors
Michel Dietz, Peter Mohr, Bernd Kuhn, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
January 22, 2020
Highly Selective, Amine-Derived Cannabinoid Receptor 2 Probes
Matthias V Westphal, Roman C Sarott, Elisabeth A Zirwes, et al.
Journal of Medicinal Chemistry
|
December 14, 2021
The Repertoire of Small-Molecule PET Probes for Neuroinflammation Imaging: Challenges and Opportunities beyond TSPO
Zhen Chen, Achi Haider, Jiahui Chen, et al.
Biorxiv : the Preprint Server for Biology
|
June 21, 2024
A highly potent, orally bioavailable pyrazole-derived cannabinoid CB2 receptor-selective full agonist for <i>in vivo</i> studies
Andrea Chicca, Daniel Batora, Christoph Ullmer, et al.
Chembiochem : a European Journal of Chemical Biology
|
January 16, 2025
Probing Native CB<sub>2</sub> Receptor Mobility in Plasma Membranes of Living Cells by Fluorescence Recovery After Photobleaching
Francesca Ciaramellano, Alessandro Leuti, Alexandrine D E Kurtz, et al.
Plos One
|
September 9, 2022
A potent and selective inhibitor for the modulation of MAGL activity in the neurovasculature
Alicia M Kemble, Benoit Hornsperger, Iris Ruf, et al.
Journal of Medicinal Chemistry
|
May 8, 2015
Discovery of a high affinity and selective pyridine analog as a potential positron emission tomography imaging agent for cannabinoid type 2 receptor
Roger Slavik, Uwe Grether, Adrienne Müller Herde, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 95) with videos related to
Sort By:
Page
of 10
Pharmaceutical Patent Analyst
|
June 11, 2021
Cannabinoid receptor type 2 ligands: an analysis of granted patents since 2010
Benjamin Brennecke, Thais Gazzi, Kenneth Atz, et al.
Biochemical Pharmacology
|
March 9, 2026
Exploring the binding kinetics of intracellular allosteric antagonists for CC chemokine receptor 2 - a key to improve insurmountable antagonism
Yao Yao, Lisa S den Hollander, Bente Bleijs, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 2, 2006
Structure-based design of indole propionic acids as novel PPARalpha/gamma co-agonists
Bernd Kuhn, Hans Hilpert, Jörg Benz, et al.
Chemmedchem
|
April 11, 2012
Comparative molecular profiling of the PPARα/γ activator aleglitazar: PPAR selectivity, activity and interaction with cofactors
Michel Dietz, Peter Mohr, Bernd Kuhn, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
January 22, 2020
Highly Selective, Amine-Derived Cannabinoid Receptor 2 Probes
Matthias V Westphal, Roman C Sarott, Elisabeth A Zirwes, et al.
Journal of Medicinal Chemistry
|
December 14, 2021
The Repertoire of Small-Molecule PET Probes for Neuroinflammation Imaging: Challenges and Opportunities beyond TSPO
Zhen Chen, Achi Haider, Jiahui Chen, et al.
Biorxiv : the Preprint Server for Biology
|
June 21, 2024
A highly potent, orally bioavailable pyrazole-derived cannabinoid CB2 receptor-selective full agonist for <i>in vivo</i> studies
Andrea Chicca, Daniel Batora, Christoph Ullmer, et al.
Chembiochem : a European Journal of Chemical Biology
|
January 16, 2025
Probing Native CB<sub>2</sub> Receptor Mobility in Plasma Membranes of Living Cells by Fluorescence Recovery After Photobleaching
Francesca Ciaramellano, Alessandro Leuti, Alexandrine D E Kurtz, et al.
Plos One
|
September 9, 2022
A potent and selective inhibitor for the modulation of MAGL activity in the neurovasculature
Alicia M Kemble, Benoit Hornsperger, Iris Ruf, et al.
Journal of Medicinal Chemistry
|
May 8, 2015
Discovery of a high affinity and selective pyridine analog as a potential positron emission tomography imaging agent for cannabinoid type 2 receptor
Roger Slavik, Uwe Grether, Adrienne Müller Herde, et al.
Page
of 10